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Background
Vaccinia immunizations have caused peri-/myocarditis. As
a result, volunteers receiving Modified Vaccinia Ankara
(MVA) are monitored with ECGs. Early Repolarization
Syndrome(ERS) has been reported in 1-2% and Left Ven-
tricular Hypertrophy(LVH) in <10% of young, healthy
populations across different ethnicities. These changes
have been described as normal ECG variations, and
according to early reviews, are more frequent in African
and Asian populations. A prevalence of 90% has been
reported for ST-Elevation in young males in several stu-
dies from industrialized and developing countries.
Methods
ECG was performed in healthy HIV negative volunteers
during screening for the Phase II ”TaMoVac01” HIV
Vaccine Trial in DarEsSalaam and Mbeya, Tanzania.
ECG variations that could potentially interfere with the
later interpretation of myocarditis/pericarditis were con-
firmed by a panel of international cardiologists and led to
exclusion from the study. These were ST-segment eleva-
tion, T-wave abnormalities, signs of LVH and ERS.
Results
263 Volunteers (mean age 24.4 years, 63.5% males) had a
baseline ECG evaluation performed. 19% of ECGs showed
ERS, 20.3% showed LVH and 77% showed ST-elevation.
22.1% of volunteers were screened out due to ECG find-
ings, none of whom had a history of cardiac disease,
although one participant had a systolic murmur which led
to echocardiogram. Dilation of the left ventricle was
diagnosed.
Conclusion
Although the prevalence of ST elevation was no higher
than expected in young males, ERS and LVH was far more
common than the literature suggested in this cohort of
clinically healthy, young Tanzanians.Exclusions were due
to the presence of more than one abnormality. None had
symptoms that were clinically relevant, although a signifi-
cant cardiac finding was revealed through echocardiogram
in one participant.
The clinical benefit of ECG screening in the context of
vaccine studies in healthy volunteers remains to be deter-
mined, but it is clear from this study that it added consid-
erably to the number of screenouts.
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